Works by Rosen, Lee


Results: 83
    1
    2
    3
    4
    5
    6

    An open-label study to describe pharmacokinetic parameters of erlotinib in patients with advanced solid tumors with adequate and moderately impaired hepatic function.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 3, p. 605, doi. 10.1007/s00280-011-1733-6
    By:
    • O'Bryant, Cindy;
    • Haluska, Paul;
    • Rosen, Lee;
    • Ramanathan, Ramesh;
    • Venugopal, Balaji;
    • Leong, Stephen;
    • Boinpally, Ramesh;
    • Franke, Amy;
    • Witt, Karsten;
    • Evans, Jeffry;
    • Belani, Chandra;
    • Gail Eckhardt, S.;
    • Ramalingam, Suresh
    Publication type:
    Article
    7

    Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 1, p. 69, doi. 10.1007/s00280-010-1431-9
    By:
    • Benjamin, Robert;
    • Schöffski, Patrick;
    • Hartmann, Jörg;
    • Oosterom, Allan;
    • Bui, Binh;
    • Duyster, Justus;
    • Schuetze, Scott;
    • Blay, Jean-Yves;
    • Reichardt, Peter;
    • Rosen, Lee;
    • Skubitz, Keith;
    • McCoy, Sheryl;
    • Sun, Yu-Nien;
    • Stepan, Daniel;
    • Baker, Laurence
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Driving Anger and Driving Behavior in Adults With ADHD.

    Published in:
    Journal of Attention Disorders, 2006, v. 10, n. 1, p. 54, doi. 10.1177/1087054705284244
    By:
    • Richards, Tracy L.;
    • Deffenbacher, Jerry L.;
    • Rosén, Lee A.;
    • Barkley, Russell A.;
    • Rodricks, Trisha
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Clinical outcomes of patients with advanced gastrointestinal stromal tumors: Safety and efficacy in a worldwide treatment-use trial of sunitinib.

    Published in:
    Cancer (0008543X), 2015, v. 121, n. 9, p. 1405, doi. 10.1002/cncr.29220
    By:
    • Reichardt, Peter;
    • Kang, Yoon‐Koo;
    • Rutkowski, Piotr;
    • Schuette, Jochen;
    • Rosen, Lee S.;
    • Seddon, Beatrice;
    • Yalcin, Suayib;
    • Gelderblom, Hans;
    • Williams, Charles C.;
    • Fumagalli, Elena;
    • Biasco, Guido;
    • Hurwitz, Herbert I.;
    • Kaiser, Pamela E.;
    • Fly, Kolette;
    • Matczak, Ewa;
    • Chen, Liang;
    • Lechuga, Maria José;
    • Demetri, George D.
    Publication type:
    Article
    36
    37
    38
    39
    40

    A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 485, doi. 10.1007/s00280-021-04308-z
    By:
    • Saif, Muhammad Wasif;
    • Becerra, Carlos R.;
    • Fakih, Marwan G.;
    • Sun, Weijing;
    • Popovic, Lazar;
    • Krishnamurthi, Smitha;
    • George, Thomas J.;
    • Rudek, Michelle A.;
    • Shepard, Dale R.;
    • Skopek, Jiri;
    • Sramek, Vladimir;
    • Zaric, Bojan;
    • Yamamiya, Ikuo;
    • Benhadji, Karim A.;
    • Hamada, Kensuke;
    • He, Yaohua;
    • Rosen, Lee
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50